Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (221-230 of 663) with videos related to

Pageof 67
Sort By:
Leukemia & Lymphoma|June 3, 2014
Multiparameter flow cytometry in the differential diagnosis of aberrant T-cell clones of unclear significanceAnna Flammiger, Ulrike Bacher, Maximilian Christopeit, et al.
Journal of Pain and Symptom Management|August 25, 2024
Death Anxiety in Patients With Advanced Cancer and Their Family CaregiversCharlotte Walbaum, Rebecca Philipp, Carsten Bokemeyer, et al.
Oncotarget|August 21, 2014
Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKLAneta Schieferdecker, Mareike Voigt, Kristoffer Riecken, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 16, 2023
Effect of depression, anxiety, and distress screeners on the need, intention, and utilization of psychosocial support services among cancer patientsFranziska Springer, Leon Sautier, Georgia Schilling, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 6, 2022
Comparison of Alternative Methods to Assess the Cost-Effectiveness of Tumor-Agnostic Therapies: A Triangulation Approach Using Larotrectinib as a Case StudyAndrew Briggs, Beth Wehler, Jennifer G Gaultney, et al.
Contemporary Clinical Trials|December 10, 2013
Effects of exercise training programs on physical performance and quality of life in patients with metastatic lung cancer undergoing palliative chemotherapy--a study protocolWiebke Jensen, Karin Oechsle, Hans Jörg Baumann, et al.
Hamostaseologie|May 7, 2025
Checkpoint Inhibitors, CAR T Cells, and the Hemostatic System: What Do We Know So Far?Christina C Rolling, Samuel Lewirt, Antonia Beitzen-Heineke, et al.
Cancer|May 17, 2002
Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinomaChristian Kollmannsberger, Karin Oechsle, Bernhard M Dohmen, et al.
Neuro-Oncology|February 13, 2010
Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2Victor-Felix Mautner, Rosa Nguyen, Hannes Kutta, et al.
Cancer Genetics and Cytogenetics|January 27, 2009
Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with ImatinibPhilippe Schafhausen, Judith Dierlamm, Carsten Bokemeyer, et al.
Pageof 67

Showing results (221-230 of 663) with videos related to

Sort By:
Pageof 67
Leukemia & Lymphoma|June 3, 2014
Multiparameter flow cytometry in the differential diagnosis of aberrant T-cell clones of unclear significanceAnna Flammiger, Ulrike Bacher, Maximilian Christopeit, et al.
Journal of Pain and Symptom Management|August 25, 2024
Death Anxiety in Patients With Advanced Cancer and Their Family CaregiversCharlotte Walbaum, Rebecca Philipp, Carsten Bokemeyer, et al.
Oncotarget|August 21, 2014
Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKLAneta Schieferdecker, Mareike Voigt, Kristoffer Riecken, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 16, 2023
Effect of depression, anxiety, and distress screeners on the need, intention, and utilization of psychosocial support services among cancer patientsFranziska Springer, Leon Sautier, Georgia Schilling, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 6, 2022
Comparison of Alternative Methods to Assess the Cost-Effectiveness of Tumor-Agnostic Therapies: A Triangulation Approach Using Larotrectinib as a Case StudyAndrew Briggs, Beth Wehler, Jennifer G Gaultney, et al.
Contemporary Clinical Trials|December 10, 2013
Effects of exercise training programs on physical performance and quality of life in patients with metastatic lung cancer undergoing palliative chemotherapy--a study protocolWiebke Jensen, Karin Oechsle, Hans Jörg Baumann, et al.
Hamostaseologie|May 7, 2025
Checkpoint Inhibitors, CAR T Cells, and the Hemostatic System: What Do We Know So Far?Christina C Rolling, Samuel Lewirt, Antonia Beitzen-Heineke, et al.
Cancer|May 17, 2002
Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinomaChristian Kollmannsberger, Karin Oechsle, Bernhard M Dohmen, et al.
Neuro-Oncology|February 13, 2010
Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2Victor-Felix Mautner, Rosa Nguyen, Hannes Kutta, et al.
Cancer Genetics and Cytogenetics|January 27, 2009
Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with ImatinibPhilippe Schafhausen, Judith Dierlamm, Carsten Bokemeyer, et al.
Pageof 67